Management controls for GMP compliance
In September 2004, the US Food and Drug Administration issued a new draft document entitled, "Guidance for Industry: Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations." Certain management-control activities are designed specifically to address GMP i...
Saved in:
Published in | Pharmaceutical Technology Vol. 29; no. 4; pp. 64 - 72 |
---|---|
Main Author | |
Format | Magazine Article Trade Publication Article |
Language | English |
Published |
Duluth, MN
Advanstar Communications
01.04.2005
MultiMedia Healthcare Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In September 2004, the US Food and Drug Administration issued a new draft document entitled, "Guidance for Industry: Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations." Certain management-control activities are designed specifically to address GMP issues such as the establishment of policies that communicate management's intentions or the establishment of a periodic, systematic review of quality data trends. Executive management must establish a clear vision that pharmaceutical manufacturing quality and compliance system is important. The GMP regulations require that companies perform, at minimum, an annual comprehensive review of batch records, complaints, failures, and other issues associated with products to determine whether changes must be made to the specifications or manufacturing control procedures [211.180(e)]. |
---|---|
ISSN: | 1543-2521 2150-7376 |